Fulgent Genetics, Inc. FLGT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$25.27M-112% | -$23.65M-282% | -$6.83M+53.5% | -$19.26M-112% | -$11.9M+14.1% | ||
| $6M+1.4% | $6.11M-1.3% | $6.04M+2.0% | $6.05M-1.6% | $5.92M-11.2% | ||
| $9.89M-6.3% | $9.28M-10.9% | $9.72M-11.0% | $10.04M-13.7% | $10.55M-8.4% | ||
| -$1.12M-742% | -$104K+71.4% | -$864K+63.4% | -$113K+75.3% | -$133K+76.1% | ||
| $9K+350% | —— | $1K+102% | —— | $2K+101% | ||
| $1.19M-42.7% | $1.85M— | $1.13M— | $2.59M+256% | $2.08M+183% | ||
| -$16.43M-463% | $15.38M+15.4% | —— | $8.26M+187% | $4.52M+405% | ||
| -$408K+38.0% | $924K— | -$102K-104% | $386K-79.0% | -$658K-169% | ||
| -$2.12M+71.6% | $12.33M— | -$1.13M+38.0% | $5.2M— | -$7.49M-70.7% | ||
| -$2.79M-247% | -$1.82M-135% | $1.37M+0.7% | —— | -$804K-3,450% | ||
| -$1K+95.2% | —— | -$1K+94.7% | -$12K— | -$21K-275% | ||
| -$627K-208% | $1.33M+281% | —— | —— | $582K+624% | ||
| -$1.39M-179% | -$71.88M-344% | -$24K+99.9% | -$34.79M— | $1.76M-65.8% | ||
| $352K+0.6% | $567K+18.9% | $485K-19.7% | $362K-69.0% | $350K-76.8% | ||
| -$381K-7.6% | -$446K+7.7% | -$470K+21.8% | -$355K+69.8% | -$354K+76.6% | ||
| $7.1M+260% | -$78.14M-412% | —— | -$30.17M-804% | -$4.43M-161% | ||
| $5.2M+10.3% | $4.98M+31.8% | $6.05M-69.0% | $6.83M-47.3% | $4.72M+16.3% | ||
| $55.57M— | —— | —— | —— | $0— | ||
| $8K+300% | —— | $3K-92.1% | —— | $2K-99.2% | ||
| $10.94M-60.6% | $11.15M+141% | $19.08M— | $53.4M— | $27.73M+159% | ||
| $40.08M+362% | —— | —— | $2.21M— | $8.68M+3,757% | ||
| $476K+1.3% | —— | —— | $1K— | $470K— | ||
| $9K— | —— | —— | —— | $0-100% | ||
| $88K-35.3% | $88K-35.3% | $88K-34.8% | $87K-37.0% | $136K+0.7% | ||
| $4.2M+123% | $447K+84.7% | $357K-17.2% | $345K-36.6% | $1.89M+12.2% | ||
| -$44.83M-301% | -$534K-63.3% | -$445K+21.5% | -$2.64M-130% | -$11.17M-298% | ||
| $3K-72.7% | $75K+156% | $15K-90.4% | $4K+144% | $11K+116% | ||
| -$26.79M-321% | -$67.45M-2,227% | $29.76M+529% | $20.6M— | $12.14M+128% | ||
| $44K-27.9% | $4K-92.0% | $4K-60.0% | —— | $61K-86.1% | ||
| -$551K-1,120% | —— | $133K-99.5% | $32.75M+5,395% | $54K-95.9% | ||
| —— | $2.48M-1.5% | $2.48M-1.5% | $2.48M-1.5% | $2.48M-1.5% | ||
| $9K+350% | —— | $1K+102% | —— | $2K+101% | ||
| -$2.12M+71.6% | $12.33M— | -$1.13M+38.0% | $5.2M— | -$7.49M-70.7% | ||
| $2.47M+2,876% | —— | $939K+48.6% | -$99K— | $83K-98.2% | ||
| -$381K-7.6% | -$446K+7.7% | -$470K+21.8% | -$355K+69.8% | -$354K+76.6% | ||
| -$2.79M-247% | -$1.82M-135% | $1.37M+0.7% | —— | -$804K-3,450% | ||
| $890K-46.3% | $942K-39.0% | $1.1M-17.8% | $1.41M-5.4% | $1.66M+40.0% | ||
| $352K+0.6% | $567K+18.9% | $485K-19.7% | $362K-69.0% | $350K-76.8% | ||
| -$1K+95.2% | —— | -$1K+94.7% | -$12K— | -$21K-275% | ||
| $1.19M-42.7% | $1.85M— | $1.13M— | $2.59M+256% | $2.08M+183% | ||
| -$199K-45.3% | -$499K-128% | -$163K-426% | -$137K— | -$137K— | ||
| $8K+300% | —— | $3K-92.1% | —— | $2K-99.2% | ||
| $88K-35.3% | $88K-35.3% | $88K-34.8% | $87K-37.0% | $136K+0.7% | ||
| $476K+1.3% | —— | —— | $1K— | $470K— | ||
| -$627K-208% | $1.33M+281% | —— | —— | $582K+624% | ||
| -$381K-7.6% | -$446K+7.7% | -$470K+21.8% | -$355K+69.8% | -$354K+76.6% | ||
| $141K— | —— | —— | —— | —— | ||
| $2.61M+12.2% | —— | —— | —— | $2.32M-51.0% | ||
| $210K— | $541K— | —— | —— | —— | ||
| -$551K+66.3% | —— | —— | —— | -$1.63M— | ||
| $1.9M+121% | -$83.12M— | $0+100% | -$37M-327% | -$9.15M-385% | ||
| $1.9M+121% | -$83.12M— | $0+100% | -$37M-327% | -$9.15M-385% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Fulgent Genetics, Inc. generate?
- Fulgent Genetics, Inc. (FLGT) generated -$105.6M in operating cash flow over the trailing twelve months.
- What is Fulgent Genetics, Inc.'s free cash flow?
- After $23.1M of capital expenditures, Fulgent Genetics, Inc.'s free cash flow was -$118.2M over the trailing twelve months, down 138.2% year over year.
- Where does Fulgent Genetics, Inc.'s cash flow data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
